Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hanson

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
Endoscopy International Open|October 20, 2022
Second exam of right colon improves adenoma detection rate: Systematic review and meta-analysis of randomized controlled trialsFaisal Kamal, Muhammad Ali Khan, Wade Lee-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Rare Germline <i>ATM</i> Variants Influence the Development of Chronic Lymphocytic LeukemiaBenjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
Blood Cancer Journal|February 2, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitorsDeepti Gadi, Stephen P Martindale, Pui Yan Chiu, et al.
Clinical and Translational Gastroenterology|December 22, 2023
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis RegistryHans H Herfarth, Anita Afzali, Monika Fischer, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Inflammatory Bowel Diseases|June 14, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world SettingMillie D Long, Anita Afzali, Monika Fischer, et al.
Haematologica|June 19, 2025
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignanciesBinu Kandathilparambil Sasi, Chiara Tarantelli, Stephen Martindale, et al.
Leukemia|November 7, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemiaDeepti Gadi, Alec Griffith, Svitlana Tyekucheva, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
Endoscopy International Open|October 20, 2022
Second exam of right colon improves adenoma detection rate: Systematic review and meta-analysis of randomized controlled trialsFaisal Kamal, Muhammad Ali Khan, Wade Lee-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2022
Rare Germline <i>ATM</i> Variants Influence the Development of Chronic Lymphocytic LeukemiaBenjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
Blood Cancer Journal|February 2, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitorsDeepti Gadi, Stephen P Martindale, Pui Yan Chiu, et al.
Clinical and Translational Gastroenterology|December 22, 2023
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis RegistryHans H Herfarth, Anita Afzali, Monika Fischer, et al.
Blood|September 30, 2004
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populationsJohn R Mackey, Carlos M Galmarini, Kathryn A Graham, et al.
Inflammatory Bowel Diseases|June 14, 2022
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world SettingMillie D Long, Anita Afzali, Monika Fischer, et al.
Haematologica|June 19, 2025
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignanciesBinu Kandathilparambil Sasi, Chiara Tarantelli, Stephen Martindale, et al.
Leukemia|November 7, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemiaDeepti Gadi, Alec Griffith, Svitlana Tyekucheva, et al.
Pageof 10